220 related articles for article (PubMed ID: 8458362)
41. [Treatment of heart failure in dogs with ACe inhibitors: comparison of quinapril and captopril].
Morisse B; Kersten U
Tierarztl Prax; 1995 Oct; 23(5):489-96. PubMed ID: 8585063
[TBL] [Abstract][Full Text] [Related]
42. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
Bahena JH; Estrella ME; Muñoz M
Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
[TBL] [Abstract][Full Text] [Related]
43. Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure.
Townend JN; Virk SJ; Qiang FX; Lawson N; Bain RJ; Davies MK
Eur Heart J; 1993 Feb; 14(2):243-50. PubMed ID: 8383598
[TBL] [Abstract][Full Text] [Related]
44. Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy.
Kontopoulos AG; Athyros VG; Didangelos TP; Papageorgiou AA; Avramidis MJ; Mayroudi MC; Karamitsos DT
Diabetes Care; 1997 Mar; 20(3):355-61. PubMed ID: 9051387
[TBL] [Abstract][Full Text] [Related]
45. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril.
Palatini P; Racioppa A; Raule G; Zaninotto M; Penzo M; Pessina AC
Clin Pharmacol Ther; 1992 Oct; 52(4):378-83. PubMed ID: 1330398
[TBL] [Abstract][Full Text] [Related]
46. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
[TBL] [Abstract][Full Text] [Related]
47. [Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure].
Gadzhiev AN
Ter Arkh; 2003; 75(1):51-5. PubMed ID: 12652958
[TBL] [Abstract][Full Text] [Related]
48. Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group.
Canter D; Frank GJ; Knapp LE; Phelps M; Quade M; Texter M
J Hum Hypertens; 1994 Mar; 8(3):155-62. PubMed ID: 8006914
[TBL] [Abstract][Full Text] [Related]
49. Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure.
Townend J; Doran J; Jones S; Davies M
Int J Cardiol; 1994 Mar; 43(3):299-304. PubMed ID: 8181887
[TBL] [Abstract][Full Text] [Related]
50. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.
Haleen SJ; Weishaar RE; Overhiser RW; Bousley RF; Keiser JA; Rapundalo SR; Taylor DG
Circ Res; 1991 May; 68(5):1302-12. PubMed ID: 1850330
[TBL] [Abstract][Full Text] [Related]
51. Overview of the clinical development of quinapril.
Frank GJ
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII13-8. PubMed ID: 2189616
[TBL] [Abstract][Full Text] [Related]
52. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
Jondeau G; Dib JC; Dubourg O; Bourdarias JP
Am J Cardiol; 1997 Mar; 79(5):635-8. PubMed ID: 9068523
[TBL] [Abstract][Full Text] [Related]
53. Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure.
Volpe M; Tritto C; DeLuca N; Rubattu S; Mele AF; Lembo G; Enea I; deCampora P; Rendina V; Romano M
Circulation; 1992 Dec; 86(6):1800-9. PubMed ID: 1451252
[TBL] [Abstract][Full Text] [Related]
54. Quinapril: a double-blind, placebo-controlled trial in essential hypertension.
Maclean D
Angiology; 1989 Apr; 40(4 Pt 2):370-81. PubMed ID: 2650581
[TBL] [Abstract][Full Text] [Related]
55. Effect of quinapril initiated during progressive remodeling in asymptomatic patients with healed myocardial infarction.
Gaudron P; Kugler L; Hu K; Fraccarollo D; Bauer W; Eilles C; Ertl G
Am J Cardiol; 2000 Jul; 86(2):139-44. PubMed ID: 10913472
[TBL] [Abstract][Full Text] [Related]
56. [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].
Skvortsov AA; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Mareev VIu; Belenkov IuN
Ter Arkh; 2005; 77(8):34-43. PubMed ID: 16206603
[TBL] [Abstract][Full Text] [Related]
57. The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention.
Texter M; Lees RS; Pitt B; Dinsmore RE; Uprichard AC
Cardiovasc Drugs Ther; 1993 Apr; 7(2):273-82. PubMed ID: 8357782
[TBL] [Abstract][Full Text] [Related]
58. Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The Benazepril Heart Failure Study Group.
Colfer HT; Ribner HS; Gradman A; Hughes CV; Kapoor A; Laidlaw JC
Am J Cardiol; 1992 Aug; 70(3):354-8. PubMed ID: 1632402
[TBL] [Abstract][Full Text] [Related]
59. A pharmacodynamic and pharmacokinetic comparison of intravenous quinaprilat and oral quinapril.
Breslin E; Posvar E; Neub M; Trenk D; Jahnchen E
J Clin Pharmacol; 1996 May; 36(5):414-21. PubMed ID: 8739020
[TBL] [Abstract][Full Text] [Related]
60. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]